Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
26 results
D1.408 - Relationship between excessive screen use and allergic diseases
D1.410 - Diet-induced obesity in children population
D1.411 - The importance of breathing exercises in the rehabilitation of allergic asthma in children
D1.416 - Pediatric Mast Cell Activation Syndrome: A Case Series Highlighting Varied Clinical Responses to Treatment and natural history
D1.409 - Unmasking the Hidden Link: Malnutrition and Allergies in Pediatric Patients
D1.412 - Educational Interventions for Allergic Children in School Settings: A Systematic Literature Review
D1.413 - Profiles of Heart Rate Variability in Asthmatic Children with Acute Exacerbation
D1.414 - Parents’ hesitancy towards vaccination: a Cross-sectional study in Saudi Arabia
D1.417 - A review of healthcare transition of young people aged 16-18 years old seen in a tertiary paediatric allergy service
D1.418 - A complex case of recurrent spontaneous angioedema in a young teenager, ‘The Devil is in the details’
D1.419 - Setbacks in the management of multiple nuts allergy in atopic children
D1.428 - Fungal Microbiome Diversity in Urban Forest Decreases Asthma and Allergic Inflammation
D1.431 - Associations of the composition of intestinal microbiota with the initial manifestations of IgE-mediated food allergy in children 6-12 months old
D1.433 - The effect of preventive administration of probiotic strain E. coli 083:H24:K31 on selected immune characteristics of eight-year-old children
D2.351 - Relapse Rate and Risk Factors After Omalizumab Treatment in Adolescents with Chronic Spontaneous Urticaria
D2.352 - Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria
D2.353 - A Single Dose of Briquilimab, An Anti-Human CD117 (c-Kit) Antibody, Protects Against Relapse of Epicutaneous Allergen-Induced Dermatitis in Mice Expressing Chimeric Human/Mouse CD117
D2.354 - Questionnaire survey of new treatments for atopic dermatitis
D2.355 - Concurrent use of dupilumab and omalizumab in severe atopic dermatitis and severe chronic urticaria
D2.356 - Real-life effectiveness of omalizumab and its impact on quality of life in patients with chronic spontaneous urticaria
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download